These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817 [TBL] [Abstract][Full Text] [Related]
10. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia. Luskin KT; White AA; Lyons JJ J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473 [TBL] [Abstract][Full Text] [Related]
11. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions. Lyons JJ; Greiner G; Hoermann G; Metcalfe DD J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond. Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315 [TBL] [Abstract][Full Text] [Related]
13. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond. Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092 [TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis and Mast Cell Disorders. Gülen T; Akin C Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750 [TBL] [Abstract][Full Text] [Related]
15. Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet? Couto ML; Silva M; Barbosa MJ; Ferreira F; Fragoso AS; Azenha Rama T Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):152-160. PubMed ID: 36927821 [TBL] [Abstract][Full Text] [Related]
16. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality. Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520 [TBL] [Abstract][Full Text] [Related]
17. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed. Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279 [TBL] [Abstract][Full Text] [Related]
18. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis. Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452 [TBL] [Abstract][Full Text] [Related]
19. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis. Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122 [TBL] [Abstract][Full Text] [Related]